See also stories tagged with Oncology
Duke University will pay $112 million to settle a whistleblower lawsuit after federal prosecutors said a research technician's fake data landed millions of dollars in federal grants, the school and the government said Monday.
The largest ever catalog of bacterial and archaeal microbes commonly populating the human body across worldwide populations has been assembled. This is the main result of a new study coordinated by Nicola Segata and Edoardo ...
A research team led by Nuno Barbosa Morais, group leader at Instituto de Medicina Molecular João Lobo Antunes (iMM) in Lisbon, computationally analysed the expression of marker genes that are associated with a "fingerprint" ...
San Diego startup Erasca said recently it has raised $64 million to develop cancer therapies with the ambitious goal of eventually curing the disease.
Many types of cancer could be more easily treated if they were detected at an earlier stage. MIT researchers have now developed an imaging system, named "DOLPHIN," which could enable them to find tiny tumors, as small as ...
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research. The difference is that the latter involves years of work, financial and personal investment and ...
Every year, more than 18 million people around the world are told, "You have cancer." In the U.S., nearly half of all men and more than one-third of women will develop some kind of cancer during their lifetimes, and 600,000-plus ...
If traditional drug delivery were a type of painting, it might be akin to paintball. With good aim, a majority of the paint ends on the bullseye, but it also drips and splashes, carrying streams of paint across the target.
In a strategic search, Johns Hopkins scientists created and screened a library of 45,000 new compounds containing chemical elements of widely used immune system suppressants, and say they found one that may prevent reperfusion ...
An international scientific group including a RUDN chemist have developed a complex copper-based compound with stronger antibacterial properties compared to analogs, and is cheaper to produce. The scientists confirmed that ...
